A Brave New World: Japan Pharma and COVID-19
A Brave New World COVID-19 or SARS Cov-2 to be precise, has changed the world in many regards. From the […]
A Brave New World COVID-19 or SARS Cov-2 to be precise, has changed the world in many regards. From the […]
Panel Recording on 6.11: Accessing Capital in the Time of COVID CATEGORIES Asian Capabilities Capital Raising Commercial Assessment Locust Walk
Panel Recording on 5.7: Biopharma Deal Maker’s Guide to Strategic Partnerships CATEGORIES Asian Capabilities Capital Raising Commercial Assessment Locust Walk
Panel Recording on 4.16: Q1 2020 Biopharma Market Conditions Live Panel CATEGORIES Asian Capabilities Capital Raising Commercial Assessment Locust Walk
Q1 2020 Biopharma Report Each quarter, Locust Walk deal team members compile key statistics and trends on strategic transactions and
LIVE Panel Discussion: Q1 2020 Biopharma Market Conditions CATEGORIES Asian Capabilities Capital Raising Commercial Assessment Locust Walk Institute Market Trends
Panel Recording on 4.2: Strategic Implications of COVID-19 on Biopharma Companies & Investors CATEGORIES Asian Capabilities Capital Raising Commercial Assessment
LIVE Panel Discussion, COVID-19: Strategic Implications on Biopharma CATEGORIES Asian Capabilities Capital Raising Commercial Assessment Locust Walk Institute Market Trends
Strategic Implications of COVID-19 on Biopharma CATEGORIES Asian Capabilities Capital Raising Commercial Assessment Locust Walk Institute Market Trends Negotiation Partnering
2019 Year End Biopharma Report Each quarter, Locust Walk deal team members compile key statistics and trends on strategic transactions and